Department of Pharmacology, Physiology and Cell Biology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.
Department of Biological Chemistry, College of Life Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.
Mol Med Rep. 2017 Nov;16(5):7229-7236. doi: 10.3892/mmr.2017.7569. Epub 2017 Sep 21.
As a novel reactive oxygen species (ROS) scavenger, deuterohemin His peptide‑6 (DhHP‑6) has been demonstrated to prolong the lifespan of Caenorhabditis elegans and has also exhibited protective effects in myocardial ischemia‑reperfusion injury. Whether similar effects occur during cerebral ischemia‑reperfusion (CIR) injury remains to be elucidated. The present study evaluated the function of DhHP‑6 and its underlying mechanisms in a middle cerebral artery occlusion (MCAO) model in rats. The focal transient MCAO model was implemented using the Longa method of ischemia for 2 h followed by reperfusion for 22 h in male Wistar rats. DhHP‑6 was administered at the onset of reperfusion via intraperitoneal injection. The infarct volume, brain edema, brain apoptosis and neurological function were evaluated 24 h following stroke. To further determine the role of DhHP‑6 in CIR injury, the levels of ROS and malondialdehyde (MDA), the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH‑Px), and the protein expression levels of B‑cell lymphoma 2 (Bcl‑2)‑associated X protein (Bax), cleaved caspase‑3, cytochrome c, Bcl‑2 and phosphorylated‑Akt/Akt were measured in ischemic cortex tissues. The results demonstrated that DhHP‑6 significantly improved infarct volume, brain edema and neurological deficits, and reduced the percentage of TUNEL‑positive cells. The levels of ROS and MDA were decreased, whereas no significant changes in the activities of SOD, CAT and GSH‑Px were observed. The levels of Bax, cleaved caspase‑3, and cytochrome c were downregulated, whereas the levels of Bcl‑2 and p‑Akt/Akt were upregulated. The results of the present study indicated that DhHP‑6 may offer therapeutic potential for cerebral ischemia. The neuroprotective effects of DhHP‑6 maybe mediated by its anti‑oxidative properties, anti‑apoptotic activities, or activation of the phosphoinositide 3‑kinase/Akt survival pathway.
作为一种新型的活性氧(ROS)清除剂,去铁血红素 His 肽-6(DhHP-6)已被证明可延长秀丽隐杆线虫的寿命,并在心肌缺血再灌注损伤中表现出保护作用。然而,其在脑缺血再灌注(CIR)损伤中的作用仍有待阐明。本研究评估了 DhHP-6 在大鼠大脑中动脉闭塞(MCAO)模型中的功能及其潜在机制。使用 Longa 缺血方法实施局灶性短暂性 MCAO 模型,缺血 2 h 后再灌注 22 h。在再灌注开始时通过腹腔注射给予 DhHP-6。在中风后 24 h 评估梗死体积、脑水肿、脑凋亡和神经功能。为了进一步确定 DhHP-6 在 CIR 损伤中的作用,测定了 ROS 和丙二醛(MDA)的水平、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GSH-Px)的活性以及 B 细胞淋巴瘤 2(Bcl-2)相关 X 蛋白(Bax)、caspase-3 剪切体、细胞色素 c、Bcl-2 和磷酸化-Akt/Akt 的蛋白表达水平。结果表明,DhHP-6 显著改善了梗死体积、脑水肿和神经功能缺损,并降低了 TUNEL 阳性细胞的百分比。ROS 和 MDA 的水平降低,而 SOD、CAT 和 GSH-Px 的活性无明显变化。Bax、caspase-3 剪切体和细胞色素 c 的水平下调,而 Bcl-2 和 p-Akt/Akt 的水平上调。本研究结果表明,DhHP-6 可能为脑缺血提供治疗潜力。DhHP-6 的神经保护作用可能是通过其抗氧化特性、抗凋亡活性或激活磷酸肌醇 3-激酶/Akt 存活途径介导的。